surmount-1 tirzepatide trial obesity without diabetes SURMOUNT 1 // Three-Year Obesty & Prevention Outcomes 💊 Could a new medication

A stratified Cox proportional hazards model, with treatment as a fixed effect and trial-level cardiovascular risk as the stratification factor, was used for the estimation of hazard ratios (HRs) and confidence intervals (CIs) comparing tirzepatide to control

However, there may be certain clinical scenarios where lifelong use of the medication is needed

Me siento exelente, he bajado de peso y de tallas Ive been using this for 3 weeks now and Ive lost 3 lbs

The FDA approved tirzepatide for managing type 2 diabetes under the brand name Mounjaro

Last verified: July 18, 2026 Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff The Short Answer New to GLP-1 pricing